Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141175 |
| CAS No | NA |
| Mol.F. | C15H19N7O3 |
| Mol.Wt. | 345.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141176 |
| CAS No | NA |
| Mol.F. | C16H12BrN7O3 |
| Mol.Wt. | 430.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141177 |
| CAS No | NA |
| Mol.F. | C16H13N7O3 |
| Mol.Wt. | 351.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141178 |
| CAS No | NA |
| Mol.F. | C6H4BrN5O3 |
| Mol.Wt. | 274.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141179 |
| CAS No | NA |
| Mol.F. | C24H25N9O3 |
| Mol.Wt. | 487.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141180 |
| CAS No | NA |
| Mol.F. | C30H35N9O5 |
| Mol.Wt. | 601.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141181 |
| CAS No | NA |
| Mol.F. | C18H29N3O2 |
| Mol.Wt. | 319.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141182 |
| CAS No | 36966-84-4 |
| Mol.F. | C6H6N2O |
| Mol.Wt. | 122.1 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0141183 |
| CAS No | NA |
| Mol.F. | C9H14N2OS |
| Mol.Wt. | 198.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141184 |
| CAS No | 70890-80-1 |
| Mol.F. | C2H2N4O2 |
| Mol.Wt. | 114.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141185 |
| CAS No | NA |
| Mol.F. | C15H9ClN4O4 |
| Mol.Wt. | 344.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141186 |
| CAS No | NA |
| Mol.F. | C18H16N2O3 |
| Mol.Wt. | 308.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141187 |
| CAS No | NA |
| Mol.F. | C16H15N3O2 |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141188 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141189 |
| CAS No | NA |
| Mol.F. | C14H11N3O3 |
| Mol.Wt. | 269.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141190 |
| CAS No | NA |
| Mol.F. | C14H10N4O5 |
| Mol.Wt. | 314.3 |
| INV STATUS | CUSTOM SYNTHESIS |